BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2474374)

  • 1. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145.
    Durocher Y; Chapdelaine A; Chevalier S
    Cancer Res; 1989 Sep; 49(17):4818-23. PubMed ID: 2474374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic epithelial cells in culture: phosphorylation of protein tyrosyl residues and tyrosine protein kinase activity.
    Bourassa C; Nguyen LT; Durocher Y; Roberts KD; Chevalier S
    J Cell Biochem; 1991 Aug; 46(4):291-301. PubMed ID: 1721913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase activities in normal and neoplastic epithelia tissue of the human upper aero-digestive tract.
    Rydell EL; Olofsson J; Hellem S; Axelsson KL
    Second Messengers Phosphoproteins; 1991; 13(4):217-29. PubMed ID: 1812286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tyrosine protein kinase from cattle cerebral cortex: purification, characteristics, protein substrates for phosphorylation and inhibitors of activity].
    Petukhov SP; Chibalin AV; Kovalenko MV; Bulargina TV; Severin ES
    Biokhimiia; 1991 Nov; 56(11):2077-96. PubMed ID: 1805985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkali-resistant protein phosphorylation and tyrosine kinase activity of epithelial cell types from normal and metaplastic canine prostates.
    Tessier S; Chapdelaine A; Chevalier S
    Mol Cell Endocrinol; 1989 Sep; 66(1):59-70. PubMed ID: 2583363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a novel transforming growth factor.
    Halper J; Moses HL
    Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification of a tyrosine kinase activity associated with a 28-kDa phosphoprotein from the particulate fraction of rat spleen.
    Borowski P; Medem S; Laufs R
    Biochem Biophys Res Commun; 1993 Jul; 194(2):691-7. PubMed ID: 8393670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Properties of tyrosine-specific protein kinase from rat sarcoma cells].
    Petukhov SP; Lebedeva EL; Bulargina TV; Severin ES
    Biokhimiia; 1987 Nov; 52(11):1808-17. PubMed ID: 2830913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
    Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
    Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
    Ravindranath N; Wion D; Brachet P; Djakiew D
    J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disulfide bonding of a human prostate tumor-associated membrane antigen recognized by monoclonal antibody D83.21.
    Starling JJ; Wright GL
    Cancer Res; 1985 Feb; 45(2):804-8. PubMed ID: 2578309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis and processing of prostatic and lysosomal acid phosphatases in a prostate carcinoma cell line PC-3SF12.
    Waheed A; Van Etten RL
    Cancer Res; 1986 Sep; 46(9):4796-803. PubMed ID: 2942240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands.
    Wilson MJ; Ruhland AR; Quast BJ; Reddy PK; Ewing SL; Sinha AA
    J Androl; 2000; 21(2):220-6. PubMed ID: 10714816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor beta.
    Lokeshwar BL; Block NL
    Cancer Res; 1992 Oct; 52(20):5821-5. PubMed ID: 1394210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific antigen in benign prostatic hyperplasia: purification and characterization.
    Chen Z; Chen H; Stamey TA
    J Urol; 1997 Jun; 157(6):2166-70. PubMed ID: 9146608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung.
    Daya-Makin M; Sanghera JS; Mogentale TL; Lipp M; Parchomchuk J; Hogg JC; Pelech SL
    Cancer Res; 1994 Apr; 54(8):2262-8. PubMed ID: 7513612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor-receptor-protein kinase interactions.
    Cohen S; Carpenter G; King L
    Prog Clin Biol Res; 1981; 66 Pt A():557-67. PubMed ID: 6273929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
    Tang DG; Li L; Chopra DP; Porter AT
    Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.